Seqirus has extensive experience in commercialising pharmaceutical and vaccine products for international partners in Australia and New Zealand. We offer a flexible partnering approach, with an ability to tailor licensing arrangements to meet the needs of our partners. We have a proven track record across a range of therapeutic areas and channels, including GP, specialist and hospital.

Consumer Pain Campaign AU 3

In-licensing for Australia and New Zealand

Our multi-award winning sales and marketing teams are recognised as leaders within the pharmaceutical industry. Seqirus is proud to have high performing primary and specialty care sales teams in Australia and New Zealand. With expertise in both private and reimbursed products, we can help you achieve your commercial goals.

Contact for In-licensing

Find out how Seqirus can help you enter the Australian and or New Zealand market by contacting our team.

Phone: +61 (0) 3 9389 2885 or +61 (0) 3 9389 2196 

Strategic Market Entry
Strategic Market Entry

Seqirus has dedicated regulatory and health economics teams to secure optimum labelling and pricing in Australia and New Zealand markets

Superior Performance
Performance Driven Teams

We have a robust track record building strong brands and achieving rapid market penetration in reimbursed and private markets in Australia and New Zealand.

We make it our own
We Make it Our Own

We make a significant investment and focus our resources during all phases of your product’s lifecycle.

Partnering flexibility
Partnering Flexibility

Our team has a great ability to adapt to our partner’s needs.


Our Company

Seqirus is one of the largest influenza vaccine manufacturers in the world.

Learn more

We focus on optimising our innovative technologies whilst also working on longer-term transformational approaches to influenza protection.

Learn more

Together with our partners, we work on the front line to protect communities from seasonal influenza and global pandemic threats.

Learn more